Friday, February 10, 2023

CerraCap Ventures Backs Israeli Disease Detection Startup

Costa Mesa-based CerraCap Ventures said today that it has backed an Israeli startup, Predicta Med, which is developing autoimmune disease detection technology based in artificial intelligence. Financial details of the investment were not announced. Predicta Med is developing a system which CerraCap says "aggregates, analyses, and enriches dat

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.